An expert panel of India's central drug authority reviewed Serum Institute's application for approval of Covishield as booster dose against COVID-19 on Friday.
from NDTV News - Latest https://ift.tt/3rZxcwb
google-site-verification: googlec4cd9e582f984ac6.html
No comments:
Post a Comment